Skip to content

Research on Quantitative Brain Functional Imaging Devices in the Diagnosis and Treatment of Mental Disorders

Research on Quantitative Brain Functional Imaging Devices in the Diagnosis and Treatment of Mental Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121379
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Basic and Clinical Research on Mood Disorders

Interventions

Schizophrenia Group:None
Depression Group:None
Healthy Control Group:None

Sponsors

West China School of Medicine/West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. In line with The Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) Regarding the diagnostic criteria for schizophrenia, depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, post-traumatic stress disorder, and anxiety disorder in DSM-5; 2. Male or female, outpatients or inpatients; 3. Race: Han Ethnicity; 4. Over 18 years old and under 65 years old; 5. Patients who have signed the informed consent form. At the same time, healthy controls were included according to the inclusion and exclusion criteria.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women and patients who are unwilling to take contraceptive measures during the study period; 2. Patients with severe or unstable diseases who were judged by the researchers as unsuitable to participate in this study; 3. Patients with a history of any neurological disorders (including epileptic seizures, brain injuries, multiple sclerosis, degenerative diseases such as acute lateral sclerosis, Parkinson's disease and movement disorders, etc.); 4. Those diagnosed with other mental disorders; 5. Patients who are currently undergoing or will receive ECT treatment within the past six months; 6. Professional drivers or patients engaged in dangerous mechanical operations; 7. Patients who have participated in other clinical studies and taken drugs provided by the sponsor within the last three months; 8. Patients with clinically significant electrocardiogram or laboratory test abnormalities;

Design outcomes

Primary

MeasureTime frame
General Information and Symptoms;Efficacy and Social Function;Laboratory Examination;Functional Near-Infrared Spectroscopy;

Secondary

MeasureTime frame
Cognitive Function;

Countries

China

Contacts

Public ContactMa Xiaohong

West china hospital, Sichuan University

maxiaohong@scu.edu.cn+86 189 8060 2101

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026